John D Quisel sold $1.9M of IRON
Chief Executive Officer at Disc Medicine, Inc.. 34,800 shares at an average of $55.33, traded Jul 9, 2025, filed Jul 11, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.9M at market
- +5Share of holdings soldSold 18% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-095338, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | MOption exercise Common Stock10b5-1 | +34,800 | $9.86 | $343k | 196,628 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stock10b5-1 | -31,207 | $55.23 | $1.7M | 165,421 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Stock10b5-1 | -3,593 | $56.20 | $202k | 161,828 | Jul 11, 2025 |
| Jul 9, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -34,800 | $0.00 | $0 | 115,375 | Jul 11, 2025 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 28Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $486k 7,378 shares | -8% | |
| 17Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $24k 353 shares | -0% | |
| 43Moderate | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $720k 11,156 shares | -14% | |
| 63Notable | Disc Medicine, Inc. | John D Quisel Chief Executive Officer | $834k 13,264 shares | -6% | |
| 47Moderate | Disc Medicine, Inc. | Jonathan Yen-Wen Yu Chief Operating Officer | $203k 3,231 shares | -6% | |
| 42Moderate | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $205k 3,256 shares | -3% | |
| 45Moderate | Disc Medicine, Inc. | Pamela Stephenson Chief Commercial Officer | $348k 5,531 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.